Charles Schwab’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$41.9M Buy
562,128
+6,101
+1% +$455K 0.01% 1204
2025
Q1
$35.3M Buy
556,027
+4,834
+0.9% +$307K 0.01% 1296
2024
Q4
$43M Buy
551,193
+8,477
+2% +$662K 0.01% 1241
2024
Q3
$43.6M Sell
542,716
-4,067
-0.7% -$327K 0.01% 1211
2024
Q2
$45.2M Sell
546,783
-2
-0% -$165 0.01% 1152
2024
Q1
$46.7M Buy
546,785
+12,091
+2% +$1.03M 0.01% 1089
2023
Q4
$45.7M Buy
534,694
+8,901
+2% +$761K 0.01% 1038
2023
Q3
$47.1M Buy
525,793
+33,294
+7% +$2.98M 0.01% 910
2023
Q2
$41.9M Buy
492,499
+6,202
+1% +$528K 0.01% 974
2023
Q1
$40.2M Sell
486,297
-9,063
-2% -$750K 0.01% 980
2022
Q4
$39M Sell
495,360
-10,875
-2% -$855K 0.01% 972
2022
Q3
$37.5M Buy
506,235
+5,123
+1% +$379K 0.01% 945
2022
Q2
$32.7M Buy
501,112
+1,349
+0.3% +$87.9K 0.01% 1038
2022
Q1
$31.6M Buy
499,763
+35,078
+8% +$2.22M 0.01% 1186
2021
Q4
$24.6M Buy
464,685
+32,469
+8% +$1.72M 0.01% 1410
2021
Q3
$30.5M Buy
432,216
+10,861
+3% +$767K 0.01% 1211
2021
Q2
$28.1M Buy
421,355
+128,346
+44% +$8.55M 0.01% 1299
2021
Q1
$32.5M Buy
293,009
+1,258
+0.4% +$140K 0.01% 1130
2020
Q4
$34.6M Sell
291,751
-8,101
-3% -$962K 0.01% 1014
2020
Q3
$26.2M Sell
299,852
-22,364
-7% -$1.95M 0.01% 1032
2020
Q2
$28.9M Sell
322,216
-99,693
-24% -$8.93M 0.01% 926
2020
Q1
$42M Buy
421,909
+25,912
+7% +$2.58M 0.02% 594
2019
Q4
$45.5M Buy
395,997
+11,767
+3% +$1.35M 0.02% 682
2019
Q3
$48.5M Sell
384,230
-79,137
-17% -$9.98M 0.03% 600
2019
Q2
$55.8M Sell
463,367
-23,201
-5% -$2.79M 0.03% 516
2019
Q1
$42.6M Buy
486,568
+14,753
+3% +$1.29M 0.03% 623
2018
Q4
$47.2M Sell
471,815
-62,390
-12% -$6.24M 0.04% 476
2018
Q3
$61.2M Buy
534,205
+1,606
+0.3% +$184K 0.04% 432
2018
Q2
$47.8M Buy
532,599
+60,135
+13% +$5.39M 0.03% 522
2018
Q1
$34.6M Sell
472,464
-82,188
-15% -$6.01M 0.03% 659
2017
Q4
$32.2M Sell
554,652
-34,727
-6% -$2.02M 0.03% 652
2017
Q3
$26.4M Buy
589,379
+20,925
+4% +$939K 0.02% 712
2017
Q2
$22.4M Buy
568,454
+24,451
+4% +$966K 0.02% 777
2017
Q1
$22.1M Buy
544,003
+93,948
+21% +$3.81M 0.02% 770
2016
Q4
$18.1M Buy
450,055
+54,130
+14% +$2.18M 0.02% 815
2016
Q3
$14.3M Sell
395,925
-71,378
-15% -$2.58M 0.02% 910
2016
Q2
$13.5M Buy
467,303
+208,101
+80% +$6.03M 0.02% 870
2016
Q1
$9.07M Buy
259,202
+43,402
+20% +$1.52M 0.01% 1103
2015
Q4
$6.96M Buy
215,800
+5,202
+2% +$168K 0.01% 1294
2015
Q3
$6.81M Buy
210,598
+13,227
+7% +$428K 0.01% 1252
2015
Q2
$8.16M Buy
197,371
+13,377
+7% +$553K 0.01% 1192
2015
Q1
$8.27M Buy
183,994
+11,182
+6% +$502K 0.01% 1139
2014
Q4
$6.47M Buy
172,812
+6,052
+4% +$226K 0.01% 1241
2014
Q3
$5.82M Buy
166,760
+661
+0.4% +$23.1K 0.01% 1242
2014
Q2
$5.86M Buy
166,099
+4,110
+3% +$145K 0.01% 1267
2014
Q1
$5.28M Sell
161,989
-3,468
-2% -$113K 0.01% 1296
2013
Q4
$6.97M Buy
165,457
+5,032
+3% +$212K 0.01% 996
2013
Q3
$6.41M Buy
160,425
+7,848
+5% +$314K 0.01% 965
2013
Q2
$6.47M Buy
+152,577
New +$6.47M 0.01% 831